|  |  | Combined | Adults | Children | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Stratifier | Predictor | OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value |
QFTG positive | None | Adults vs Children | 1.94 | 1.05–3.60 | 0.035 | – | – | – | – | – | – |
 | IC ss + vs IC ss- | 1.76 | 1.02–3.06 | 0.043* | 1.88 | 0.98–3.61 | 0.057 | 1.36 | 0.48–3.94 | 0.58 | |
 | Symptoms | 1.61 | 0.79–3.29 | 0.1884 | 1.57 | 0.68–3.64 | 0.289 | 1.625 | 0.40–6.54 | 0.494 | |
 | High household risk | 1.97 | 1.09–3.54 | 0.024* | 1.81 | 0.90–3.66 | 0.097 | 2.53 | 0.83–7.69 | 0.102 | |
Index Case ss+ | High household risk | 2.47 | 1.10–5.50 | 0.027* | 2.16 | 0.83–5.62 | 0.115 | 5.06 | 0.96–26.66 | 0.056 | |
TST positive | None | IC ss+ | 1.75 | 0.75–4.09 | 0.195 | 1.50 | 0.05–40.63 | 0.810 | 1.66 | 0.68–4.08 | 0.268 |
 | High household risk | 0.85 | 0.35–2.07 | 0.720 | NA | NA | NA | 0.88 | 0.34–2.28 | 0.792 | |
Symptoms | None | IC ss+ | 1.92 | 1.02–3.58 | 0.04* | 2.63 | 1.18–5.89 | 0.018* | 1.02 | 0.35–2.98 | 0.965 |
None | High household risk | 1.03 | 0.53–2.01 | 0.918 | 1.2 | 0.53–2.68 | 0.654 | 0.76 | 0.23–2.55 | 0.655 |